A search of publicly available databases showed that the expression of the AKR1C1 and AKR1C2 genes is inversely correlated with the in vitro sensitivity to alpelisib in a large panel of breast cancer cell lines. This evidence concerns the gene AKR1C2 and breast carcinoma.